Shedding of active tissue factor by aortic smooth muscle cells (SMCs) undergoing apoptosis

Summary

As apoptosis of neo-intimal SMCs is a feature of advanced atherosclerotic plaques, the procoagulant properties of SMCs of synthetic phenotype undergoing apoptosis were investigated. SMCs isolated from rat aorta obtained 10 days after balloon injury, previously found to up-regulate Tissue Factor (TF) and Tissue Factor Inhibitor (TFPI) and to release large amounts of TFPI (Ghrib et al. Thromb Haemost 2002;87:1043-50), were sensitive to the apoptosis induced by Fas-ligand. During this process, surface TF activity rose by a factor 10 over 6 hours, in parallel with a proportional increase in prothrombinase, while TF protein expressed at the membrane significantly decreased. The microparticles (MPs) produced during SMC death bore intact and functional TF, but the release of TFPI did not change, so that the balance shifted to a procoagulant state during apoptosis. Shed MPs enhanced thrombus formation in flowing whole blood over collagen coated-glass slides. Apoptotic SMCs in atherosclerotic plaques represent a reservoir of highly thrombogenic material, released into the blood stream in case of spontaneous or mechanical plaque disruption.

Keywords

Apoptosis - arterial thrombosis - smooth muscle cells - tissue factor

• References

• 1 Marmur JD, Thiruvikraman SV, Fyfe BS. et al. Identification of active tissue factor in human coronary atheroma. Circulation 1996; 94: 1226-32.
• 2 Toschi V, Gallo R, Lettino M. et al. Tissue factor modulates the thrombogenicity of human atherosclerotic plaques. Circulation 1997; 95: 594-9.
• 3 Kunzelmann-Marche C, Satta N, Toti F. et al. The influence exerted by a restricted phospholipid microenvironment on the expression of tissue factor activity at the cell plasma membrane surface. Thromb Haemost 2000; 83: 282-9.
• 4 Mulder AB, Smit JW, Bom VJJ, Ruiters MHJ, Halie MR, Van der Meer J. Association of smooth muscle cell tissue factor with caveolae. Blood 1996; 88 (04) 1306-13.
• 5 Broze GJJ. Tissue factor pathway inhibitor. Thromb Haemost 1995; 74 (01) 90-3.
• 6 Bochaton-Piallat ML, Gabbiani F, Redard M, Desmoulière A, Gabbiani G. Apoptosis participates in cellularity regulation during rat aortic intimal thickening. Am J Pathol 1995; 146: 1059-64.
• 7 Han DKM, Haudenschil CC, Hong MK, Tinkle BT, Leon MB, Liau G. Evidence for apoptosis in human atherogenesis and in a rat vascular injury model. Am J Pathol 1995; 147: 267-77.
• 8 Mallat Z, Hugel B, Ohan J, Lesèche G, Freyssinet JM, Tedgui A. Shed membrane microparticles with procoagulant potential in human atherosclerotic plaques. Circulation 1999; 99: 348-53.
• 9 Bonderman D, Teml A, Jakowitsch J. et al. Coronary no-reflow is caused by shedding of active tissue factor from dissected athero-sclerotic plaque. Blood 2002; 99: 2791-800.
• 10 Geng Y-J, Henderson LE, Levesque EB, Muszynski M, Libby P. Fas is expressed in human atherosclerotic intima and promotes apoptosis of cytokine-primed human vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 1997; 17: 2200-8.
• 11 Ghrib F, Brisset A-C, Dupouy D. et al. The expression of tissue factor and tissue factor pathway inhibitor in aortic smooth muscle cells is up-regulated in synthetic compared to contractile phenotype. Thromb Haemost 2002; 87: 1051-6.
• 12 Cadroy Y, Bossavy JP, Thalamas C, Sagnard L, Sakariassen K, Boneu B. Early potent antithrombotic effect with combined aspirin and a loading dose of clopidogrel on experimental arterial thrombogenesis in humans. Circulation 2000; 101: 2823-8.
• 13 Freyssinet JM, Toti F, Hugel B. et al. Apoptosis in vascular disease. Thromb Haemost 1999; 82: 727-35.
• 14 Boyle JJ, Bowyer DE, Weissberg PL, Bennett MR. Human blood-derived macrophages induce apoptosis in human plaque-derived vascular smooth muscle cells by fas-ligand/fas interaction. Arterioscler Thromb Vasc Biol 2001; 21: 1402-7.
• 15 Pollman MJ, Hall JL, Gibbons GH. Determinants of vascular smooth muscle cell apoptosis after balloon angioplasty injury -Influence of redox state and cell phenotype. Circ Res 1999; 84: 113-21.
• 16 Crawley J, Lupu F, Westmuckett AD, Severs NJ, Kakkar VV, Lupu C. Expression, localization, and activity of tissue factor pathway inhibitor in normal and atherosclerotic human vessels. Arterioscler Thromb Vasc Biol 2000; 20: 1362-73.
• 17 Caplice NM, Mueske CS, Kleppe LS, Simari RD. Presence of tissue factor pathway inhibitor in human atherosclerotic plaques is associated with reduced tissue factor activity. Circulation 1998; 98: 1051-7.
• 18 Kaikita K, Takeya M, Ogawa H, Suefuji H, Takahashi K. Co-localization of tissue factor and tissue factor pathway inhibitor in coronary atherosclerosis. J Pathol 1999; 188 (02) 180-8.
• 19 Schecter AD, Giesen PLA, Taby O. et al. Tissue factor expression in human arterial smooth muscle cells - TF is present in three cellular pools after growth factor stimulation. J Clin Invest 1997; 100 (09) 2276-85.
• 20 Ruf W, Rehemtulla A, Edgington TS. Phospholipid-independent and dependent interactions required for tissue factor receptor and cofactor function. JBC 1991; 266 (04) 2158-66.
• 21 Schecter AD, Spirn B, Rossikhina M. et al. Release of active tissue factor by human arterial smooth muscle cells. Circulation Research 2000; 87: 126-32.
• 22 Thiruvikraman SV, Guha A, Roboz J, Taubman MB, Nemerson Y, Fallon JT. In situ localization of tissue factor in human athero-sclerotic plaques by binding of digoxigenin-labeled factors VIIa and X. Lab Invest 1996; 75 (04) 451-61.
• 23 Kockx MM, De Meyer GRY, Muhring J, Jacob W, Bult H, Herman AG. Apoptosis and related proteins in different stages of human atherosclerotic plaques. Circulation 1998; 97: 2307-15.
• 24 Giesen PLA, Rauch U, Bohrmann B. et al. Blood-borne tissue factor : another view of thrombosis. Proc Natl Acud Scl 1999; 95: 2311-5.
• 25 Hathcock JJ, Hall CL, Turitto VT. Active tissue factor shed from human arterial smooth muscle cells adheres to artificial surfaces. J Biomater Sci Polym Edn 2000; 11: 1211-25.